Literature DB >> 24671468

[Neuroendocrine neoplasms of the distal jejunum and ileum].

M Anlauf1, B Sipos, I Boeck, S E Baldus, S Heikaus, M Krausch, W T Knoefel, N Begum, P Goretzki, M Schott, C J Auernhammer, B Cremer, A Rinke, S Ezziddin, C Fottner, G Pöpperl, H Lahner, D Hörsch, H E Gabbert, P Komminoth, A Perren, G Klöppel, B Wiedenmann, M Pavel, U Pape.   

Abstract

Neuroendocrine neoplasms (NEN) of the distal jejunum and ileum derive from serotonin-producing enterochromaffin (EC) cells. Due to their low proliferation rate and their infiltrative growth, they are often discovered at an advanced disease stage when metastasis has already occurred. The biology of these tumours is different from other NEN of the digestive tract. In order to standardise and improve diagnosis and therapy, the guidelines for the diagnosis and clinical management of jejuno-ileal NEN as well as for the management of patients with liver and other distant metastases from NEN were revised by the European Neuroendocrine Tumour Society (ENETS) in 2012. This review focuses on aspects relevant for surgical pathology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24671468     DOI: 10.1007/s00292-013-1888-5

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  23 in total

1.  ENETS Consensus Guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas.

Authors:  Ulrich-Frank Pape; Aurel Perren; Bruno Niederle; David Gross; Thomas Gress; Frederico Costa; Rudolf Arnold; Timm Denecke; Ursula Plöckinger; Ramon Salazar; Ashley Grossman
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

2.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

3.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification.

Authors:  Günter Klöppel; Anne Couvelard; Aurel Perren; Paul Komminoth; Anne-Marie McNicol; Ola Nilsson; Aldo Scarpa; Jean-Yves Scoazec; Bertram Wiedenmann; Mauro Papotti; Guido Rindi; Ursula Plöckinger
Journal:  Neuroendocrinology       Date:  2009-08-28       Impact factor: 4.914

4.  ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biochemical markers.

Authors:  Dermot O'Toole; Ashley Grossman; David Gross; Gianfranco Delle Fave; Jaroslava Barkmanova; Juan O'Connor; Ulrich-Frank Pape; Ursula Plöckinger
Journal:  Neuroendocrinology       Date:  2009-08-28       Impact factor: 4.914

5.  Correlation of immunohistopathological expression of somatostatin receptor 2 with standardised uptake values in 68Ga-DOTATOC PET/CT.

Authors:  Matthias Miederer; Stefan Seidl; Andreas Buck; Klemens Scheidhauer; Hans-Jürgen Wester; Markus Schwaiger; Aurel Perren
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-20       Impact factor: 9.236

6.  Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome.

Authors:  Henning Jann; Stephanie Roll; Anne Couvelard; Olivia Hentic; Marianne Pavel; Jacqueline Müller-Nordhorn; Martin Koch; Christoph Röcken; Guido Rindi; Philippe Ruszniewski; Bertram Wiedenmann; Ulrich-Frank Pape
Journal:  Cancer       Date:  2011-01-18       Impact factor: 6.860

Review 7.  Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

Authors:  R Garcia-Carbonero; J Capdevila; G Crespo-Herrero; J A Díaz-Pérez; M P Martínez Del Prado; V Alonso Orduña; I Sevilla-García; C Villabona-Artero; A Beguiristain-Gómez; M Llanos-Muñoz; M Marazuela; C Alvarez-Escola; D Castellano; E Vilar; P Jiménez-Fonseca; A Teulé; J Sastre-Valera; M Benavent-Viñuelas; A Monleon; R Salazar
Journal:  Ann Oncol       Date:  2010-02-05       Impact factor: 32.976

Review 8.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

9.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.

Authors:  Anja Rinke; Hans-Helge Müller; Carmen Schade-Brittinger; Klaus-Jochen Klose; Peter Barth; Matthias Wied; Christina Mayer; Behnaz Aminossadati; Ulrich-Frank Pape; Michael Bläker; Jan Harder; Christian Arnold; Thomas Gress; Rudolf Arnold
Journal:  J Clin Oncol       Date:  2009-08-24       Impact factor: 44.544

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  4 in total

Review 1.  [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].

Authors:  G Klöppel
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

Review 2.  [Surgical aspects of neuroendocrine tumors of the small intestine].

Authors:  F Weber; H Dralle
Journal:  Chirurg       Date:  2018-06       Impact factor: 0.955

Review 3.  Novel PET tracers: added value for endocrine disorders.

Authors:  Sébastien Bergeret; Judith Charbit; Catherine Ansquer; Géraldine Bera; Philippe Chanson; Charlotte Lussey-Lepoutre
Journal:  Endocrine       Date:  2019-03-14       Impact factor: 3.633

4.  Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours.

Authors:  Moritz Jesinghaus; Jelte Poppinga; Bettina Lehman; Elisabeth Maurer; Annette Ramaswamy; Albert Grass; Pietro Di Fazio; Anja Rinke; Carsten Denkert; Detlef K Bartsch
Journal:  Cancers (Basel)       Date:  2022-08-17       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.